Oruka Therapeutics, Inc. ORKA Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s change in accrued liabilities?
- Oruka Therapeutics, Inc. (ORKA) reported change in accrued liabilities of -$1.3M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s change in accrued liabilities changed year-over-year?
- Oruka Therapeutics, Inc.'s change in accrued liabilities decreased by 156.3% year-over-year, from $2.32M to -$1.3M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.